title: First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group.
authors.affiliation: Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Via Pansini 5, 80131 Napoli, Italy. colao@unina.it
authors.forename: A
authors.initials: A
authors.lastname: Colao
authors.forename: E
authors.initials: E
authors.lastname: Martino
authors.forename: P
authors.initials: P
authors.lastname: Cappabianca
authors.forename: R
authors.initials: R
authors.lastname: Cozzi
authors.forename: M
authors.initials: M
authors.lastname: Scanarini
authors.forename: E
authors.initials: E
authors.lastname: Ghigo
mesh_terms: D000172:Acromegaly / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D000236:Adenoma / Q000601:surgery; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000627:therapeutic use; D004873:Ergolines / Q000627:therapeutic use; D006801:Humans; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D018491:Dopamine Agonists; D004873:Ergolines; D013004:Somatostatin; D000077465:Cabergoline